drugset / Trial / NCT03824171
Evaluating the Pharmacokinetic Characteristics of AD-102 in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetic characteristics of AD-102 in healthy male subjects
Timeline
- Start
- 2019-02-28
- Primary completion
- 2019-03-27
- Completion
- 2019-04-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 800 iu | Oral |
| Subject | Raloxifene | Other / unclassified | 45 mg | Oral |
| Subject | Raloxifene | Other / unclassified | 60 mg | Oral |